Skip to main content

Eli Lilly and Company income statement

  • LLY · NYSE
  • Pharmaceuticals
  • S&P 500
$1443.50+1.14%Close 13 Nov 2026 · Market value $1.37T

Eli Lilly and Company reported revenue of $65.2 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 44.7% from fiscal 2024. Net income was $20.6 billion and diluted earnings per share $22.95.

From Eli Lilly and Company's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Eli Lilly and Company income statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Revenue$18.63B$20.37B$21.84B$23.08B$24.29B$22.60B$23.11B$19.62B$19.96B$21.22B$19.97B$21.49B$22.32B$24.54B$28.32B$28.54B$34.12B$45.04B$65.18B$86.46B
Revenue growth—+9.3%+7.2%+5.7%+5.2%−6.9%+2.3%−15.1%+1.7%+6.3%−5.9%+7.6%+3.8%+9.9%+15.4%+0.8%+19.6%+32.0%+44.7%—
Cost of revenue$4.25B$4.38B$4.25B$4.37B$5.07B$4.80B$4.91B$4.93B$5.04B$5.71B$4.45B$4.68B$4.72B$5.48B$7.31B$6.63B$7.08B$8.42B$11.05B$14.15B
Gross profit$14.38B$16.00B$17.59B$18.71B$19.22B$17.81B$18.20B$14.68B$14.92B$15.51B$15.53B$16.81B$17.60B$19.06B$21.01B$21.91B$27.04B$36.63B$54.13B$72.31B
Gross margin77.2%78.5%80.6%81.1%79.1%78.8%78.8%74.9%74.8%73.1%77.7%78.2%78.8%77.7%74.2%76.8%79.2%81.3%83.0%83.6%
Research and development$3.49B$3.84B$4.33B$4.88B$5.02B$5.28B$5.53B$4.73B$4.80B$5.31B$5.10B$5.05B$5.59B$5.98B$6.93B$7.19B————
Selling, general and administrative$6.10B$6.63B$6.89B$7.05B$7.88B$7.51B$7.13B$6.62B$6.53B$6.53B$5.98B$5.98B$6.21B$6.12B$6.43B$6.44B$7.40B$8.59B$11.09B$12.62B
Operating expenses———$11.76B———$11.53B—$11.95B——$11.93B———————
Operating income—−$1.08B$5.62B$6.95B$5.54B$5.59B$6.05B$3.15B$2.95B$3.56B$2.53B$3.92B$5.67B$7.59B$6.50B$7.14B$7.04B$13.46B$26.63B$34.99B
Operating margin—−5.3%25.7%30.1%22.8%24.7%26.2%16.1%14.8%16.8%12.7%18.3%25.4%30.9%22.9%25.0%20.6%29.9%40.9%40.5%
Interest expense—$228.3M$261.3M$185.5M$186.0M$177.8M$160.1M$148.8M$161.2M$185.2M$225.0M$242.5M$400.6M$359.6M$339.8M$331.6M$486.0M$781.0M$895.0M—
Other income and expense—$26.10M−$229.5M−$5.00M−$179.0M$674.0M$518.9M$340.5M$100.6M$112.8M$301.5M$145.6M$291.6M$1.17B−$201.6M−$320.9M$97.00M−$219.0M−$571.0M−$107.0M
Income before tax$3.88B−$1.31B$5.36B$6.77B$5.35B$5.41B$5.89B$3.00B$2.79B$3.37B$2.30B$3.68B$5.27B$7.23B$6.16B$6.81B$6.55B$12.68B$25.73B$34.77B
Income tax expense$923.8M$764.3M$1.03B$1.46B$1.00B$1.32B$1.20B$609.8M$381.6M$636.4M$2.39B$529.5M$628.0M$1.04B$573.8M$561.6M$1.31B$2.09B$5.09B$7.19B
Effective tax rate23.8%−58.5%19.2%21.5%18.7%24.4%20.5%20.3%13.7%18.9%104%14.4%11.9%14.3%9.3%8.3%20.0%16.5%19.8%20.7%
Net income$2.95B−$2.07B$4.33B$5.07B$4.35B$4.09B$4.68B$2.39B$2.41B$2.74B−$204.1M$3.23B$8.32B$6.19B$5.58B$6.24B$5.24B$10.59B$20.64B$27.58B
Net margin15.8%−10.2%19.8%22.0%17.9%18.1%20.3%12.2%12.1%12.9%−1.0%15.0%37.3%25.2%19.7%21.9%15.4%23.5%31.7%31.9%
Net income to common shareholders—−$2.07B$4.33B$5.07B$4.35B$4.09B——————————————
EPS · diluted—−$1.89$3.94$4.58$3.90$3.66$4.32$2.23$2.26$2.58−$0.19$3.13$8.89$6.79$6.12$6.90$5.80$11.71$22.95$30.81
Diluted weighted average shares—1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.0B936M913M912M905M903M904M899M895M
Basic weighted average shares—1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.1B1.0B931M908M907M902M900M901M897M894M
EBITDA—$43.30M$6.92B$8.28B$6.91B$7.05B$7.50B$4.53B$4.38B$5.06B$4.10B$5.53B$6.90B$8.91B$8.04B$8.66B$8.57B$15.23B$28.62B$37.16B
EBITDA margin—0.2%31.7%35.9%28.4%31.2%32.4%23.1%21.9%23.8%20.5%25.7%30.9%36.3%28.4%30.3%25.1%33.8%43.9%43.0%
Depreciation & amortization−$1.05B$1.12B$1.30B$1.33B$1.37B$1.46B$1.45B$1.38B$1.43B$1.50B$1.57B$1.61B$1.23B$1.32B$1.55B$1.52B$1.53B$1.77B$2.00B$2.17B
Stock-based compensation−$282.0M$255.3M$368.5M$231.0M$147.4M$141.5M$144.9M$156.0M$217.8M$255.3M$281.3M$279.5M$312.4M$308.1M$342.8M$371.1M$629.0M$646.0M$626.0M$698.0M
Dividends per share—$1.90$1.96$1.96$1.96————$2.05$2.12$2.33$2.68$3.07$3.53$4.07$4.69$5.40$6.23—

Quarterly

Eli Lilly and Company income statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$9.35B$8.77B$11.30B$11.44B$13.53B$12.73B$15.56B$17.60B$19.29B$19.80B$22.97B$24.40B
Cost of revenue$1.79B$1.67B$2.17B$2.17B$2.40B$2.23B$2.45B$3.01B$3.37B$3.58B$3.27B$3.93B
Gross profit$7.57B$7.09B$9.13B$9.27B$11.13B$10.50B$13.11B$14.59B$15.92B$16.22B$19.71B$20.46B
Gross margin80.9%80.9%80.8%81.0%82.2%82.5%84.3%82.9%82.5%81.9%85.8%83.9%
Selling, general and administrative$1.92B$1.95B$2.12B$2.10B$2.42B$2.47B$2.75B$2.74B$3.13B$2.93B$3.43B$3.13B
Operating income$2.65B$2.72B$3.70B$1.78B$5.26B$3.70B$7.03B$7.41B$8.49B$8.91B$8.98B$8.61B
Operating margin28.3%31.0%32.7%15.6%38.9%29.1%45.2%42.1%44.0%45.0%39.1%35.3%
Interest expense$138.2M$179.6M$183.6M$192.7M$224.7M$243.7M$249.0M$179.6M$222.6M———
Other income and expense$121.3M$27.10M−$197.6M$62.00M−$110.5M−$239.0M−$90.00M−$132.0M−$109.0M−$65.00M$269.0M−$202.0M
Income before tax$2.51B$2.54B$3.52B$1.59B$5.04B$3.46B$6.78B$7.23B$8.27B$8.85B$9.25B$8.41B
Income tax expense$319.1M$293.2M$550.2M$618.1M$628.9M$697.0M$1.12B$1.65B$1.63B$1.45B$2.15B$1.96B
Effective tax rate12.7%11.6%15.6%38.9%12.5%20.2%16.5%22.8%19.7%16.4%23.3%23.3%
Net income$2.19B$2.24B$2.97B$970.3M$4.41B$2.76B$5.66B$5.58B$6.64B$7.40B$7.09B$6.45B
Net margin23.4%25.6%26.3%8.5%32.6%21.7%36.4%31.7%34.4%37.4%30.9%26.4%
EPS · diluted$2.42$2.48$3.28$1.07$4.88$3.06$6.29$6.21$7.39$8.26$7.94$7.22
Diluted weighted average shares904M904M904M905M903M901M900M899M898M896M894M893M
Basic weighted average shares900M901M901M901M900M899M898M897M896M895M892M892M
EBITDA$3.03B$3.12B$4.12B$2.25B$5.75B$4.16B$7.50B$7.88B$9.07B$9.42B$9.51B$9.15B
EBITDA margin32.4%35.5%36.4%19.7%42.5%32.7%48.2%44.8%47.0%47.6%41.4%37.5%
Depreciation & amortization$387.7M$400.6M$414.4M$466.8M$484.8M$463.0M$478.0M$470.0M$586.0M$509.0M$534.0M$545.0M
Stock-based compensation$120.2M$159.4M$211.1M$133.2M$141.9M$154.0M$185.0M$151.0M$136.0M$161.0M$201.0M$200.0M
Dividends per share$2.43—$2.60$0.00$2.80—$3.00$0.00$3.23—$3.46$0.00

The main figures as JSON and plain text. See data and methodology.

LLY in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.